AstraZeneca to Acquire Icosavax in Deal Valued at Approximately $1.1 Billion - Global Search, Local Care | The Future of Medical Consultation


ChatMedical.AI, an innovator in AI healthcare, is a key subsidiary of UL Cell Therapeutic, a leading medical research firm based in Singapore with significant operations in North America and Asia